Studies Tie Heart Drugs to Diabetes and Breast Cancer

Reprint from DietBlog:

Two separate studies have linked the heart drugs Lipitor (used to treat high cholesterol) and Digoxin (prescribed to patients with heart failure or abnormal heart beats) to higher risk of diabetes and breast cancer, respectively.

According to the Lipitor website, people with diabetes are advised to consult their doctor before starting Lipitor (known generically as Atorvastatin). And in 2008, research implicated Digoxin (marketed as Lanoxin and Digitek) with increased risk of breast cancer.

Read the full article.